Limitations, agreements, and source contact

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma · Source last updated 2014-12-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

sarc@sarctrials.org

organization

SARC

phone

(734) 930-7600

title

Research Project Manager

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice